Skip to main
AERI
AERI logo

Aerie Pharmaceuticals (AERI)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Aerie Pharmaceuticals (AERI) Stock

About Aerie Pharmaceuticals (AERI)

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and...read more
Market cap$753.62M
Today's volume
Revenue (TTM)
Avg. daily volume1.53M
EBITDA (TTM)
Open
Price / earnings ratio-19.89x
Today's range
Debt / equity
52 week range$4.81 - $15.37
5 year debt / equity
Beta (LTM)0.9x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 3, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 22, 2025, the market cap for AERI stock is $753.62M

The current P/E ratio for AERI stock is -19.89

The 52-week high for AERI stock is $15.37. The current AERI stock price $undefined is 100.00% below its 52-week high

The 52-week low for AERI stock is $4.81. The current AERI stock price $undefined has increased 100.00% from its 52-week low

No, the AERI stock does not pay dividends to its shareholders

How to buy AERI stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in AERI stock

    Navigate to the Explore page. Then, type AERI into the search bar. When you see AERI stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased AERI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Aerie Pharmaceuticals Stock Earnings

The value each AERI share was expected to gain vs. the value that each AERI share actually gained.

Aerie Pharmaceuticals (AERI) reported Q3 2022 earnings per share (EPS) of -$0.27, beating estimates of -$0.44 by 38.64%. In the same quarter last year, Aerie Pharmaceuticals's earnings per share (EPS) was -$0.72. Aerie Pharmaceuticals is expected to release next earnings on 11/03/2022, with an earnings per share (EPS) estimate of $0.

Buy Aerie Pharmaceuticals (AERI) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.